Validation of RDQ questionnaire

Study identifier:D9914C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d.

Medical condition

Gastroesophageal Reflux

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

350

Study type

Interventional

Age

18 Years - 79 Years

Date

Study Start Date: 01 Sept 2005
Primary Completion Date: -
Study Completion Date: 01 Nov 2006

Study design

Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria